All articles tagged: Chlamydial pneumonia (J16.0)


Evalytics 15 April at 05.51 PM Chlamydia vaccine shows promise in early trial A chlamydia vaccine in early trials shows promise, offering hope for combating the prevalent sexually transmitted infection. The vaccine demonstrated effectiveness and safety in its initial testing phase. Further research is needed to assess its long-term efficacy and potential for widespread use. 0 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Evalytics 05 December at 06.22 PM Pathogens use force to breach immune defenses, study finds Indiana University researchers have uncovered a new method pathogens use to breach the body's immune defenses. Instead of releasing chemical substances, some pathogens apply physical force during entry into host cells, allowing them to evade degradation. This finding offers a potential breakthrough in combating intracellular infections like tuberculosis, malaria, and chlamydia by targeting pathoge 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn

Evalytics 15 April at 05.51 PM

Chlamydia vaccine shows promise in early trial

A chlamydia vaccine in early trials shows promise, offering hope for combating the prevalent sexually transmitted infection. The vaccine demonstrated effectiveness and safety in its initial testing phase. Further research is needed to assess its long-term efficacy and potential for widespread use.

0 Likes

0 Comments

Evalytics 05 December at 06.22 PM

Pathogens use force to breach immune defenses, study finds

Indiana University researchers have uncovered a new method pathogens use to breach the body's immune defenses. Instead of releasing chemical substances, some pathogens apply physical force during entry into host cells, allowing them to evade degradation. This finding offers a potential breakthrough in combating intracellular infections like tuberculosis, malaria, and chlamydia by targeting pathoge

1 Likes

0 Comments


Medical xPress 30 June at 07.40 AM Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts say Intrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 27 June at 03.19 PM Immunoglobulin Replacement Therapy Beneficial for Blood Cancers Immunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 26 June at 04.59 PM When Was the Last Time You Really Talked With Your Patient? My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 23 June at 09.21 PM Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2D ORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 22 June at 06.00 PM Fenofibrate Slows Diabetic Retinopathy Progression ORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 22 June at 06.00 PM Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic Stroke TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn

Medical xPress 22 June at 05.20 PM Lawsuit could challenge trust in Ozempic and other popular weight loss drugs The manufacturers of the most popular weight loss drugs are being challenged in court. 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
HealthDay 21 June at 03.38 PM Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is Low The overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 13 June at 06.56 PM Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break? Finding a way to dissociate the activity of effector T cells from regulatory T cells could make immune checkpoint inhibitors more effective in the 60% of melanoma patients who do not benefit or develop resistance to the drugs... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn
Medpage Today 08 June at 04.00 PM Here Are the Top Supreme Court Health Cases to Watch By early July, the Supreme Court will release its most controversial rulings for the 2023-2024 term. The Court's 6-3 conservative supermajority has already overturned Roe v. Wade, sharply limited affirmative action, expanded... 1 Likes 0 Comments 0 Shares Facebook Twitter LinkedIn